Can a coping workshop ease hopelessness in ovarian cancer?
NCT ID NCT06666218
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a workshop called HOPE designed to reduce feelings of hopelessness and helplessness in patients with recurrent ovarian cancer. Sixty participants will either attend the workshop or receive usual care. Researchers will measure whether the workshop is feasible, acceptable, and actually improves emotional well-being.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
behavioral intervention (HOPE workshop)
What this could lead to
If it works, this could provide a simple, effective way to improve emotional well-being and quality of life for people with recurrent ovarian cancer.
What could go wrong
This is a small, early feasibility study (60 participants) that is currently suspended. It focuses on mental health, not survival, and may not show a clear benefit.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT OVARIAN CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98109, United States